-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Neutral on Teladoc Health, Raises Price Target to $7

Benzinga·05/05/2026 15:25:22
Listen to the news
Citigroup analyst Daniel Grosslight maintains Teladoc Health (NYSE:TDOC) with a Neutral and raises the price target from $6 to $7.